URO17 Trademark

Trademark Overview

On Tuesday, May 21, 2019, a trademark application was filed for URO17 with the United States Patent and Trademark Office. The USPTO has given the URO17 trademark a serial number of 88440326. The federal status of this trademark filing is REGISTERED as of Tuesday, January 5, 2021. This trademark is owned by KDx Diagnostics, Inc.. The URO17 trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing
uro17

General Information

Serial Number88440326
Word MarkURO17
Filing DateTuesday, May 21, 2019
Status700 - REGISTERED
Status DateTuesday, January 5, 2021
Registration Number6240571
Registration DateTuesday, January 5, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 17, 2019

Trademark Statements

Goods and ServicesDiagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing
Pseudo MarkURO SEVENTEEN

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 6, 2019
Primary Code005
First Use Anywhere DateFriday, October 23, 2020
First Use In Commerce DateFriday, October 23, 2020

Trademark Owner History

Party NameKDx Diagnostics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Jose, CA 95124
Party NameKDx Diagnostics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCampbell, CA 95008
Party NameKDx Diagnostics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCampbell, CA 95008

Trademark Events

Event DateEvent Description
Friday, May 24, 2019NEW APPLICATION ENTERED
Thursday, June 6, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 7, 2019ASSIGNED TO EXAMINER
Friday, August 9, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 28, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2019PUBLISHED FOR OPPOSITION
Tuesday, September 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 8, 2020SOU TEAS EXTENSION RECEIVED
Friday, May 8, 2020SOU EXTENSION 1 FILED
Friday, May 8, 2020SOU EXTENSION 1 GRANTED
Tuesday, May 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 3, 2020TEAS STATEMENT OF USE RECEIVED
Saturday, November 14, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 3, 2020USE AMENDMENT FILED
Saturday, November 14, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 2, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 3, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 5, 2021REGISTERED-PRINCIPAL REGISTER
Monday, June 7, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 7, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 5, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

buffers reagents disease testing antibodies monoclonal kits consisting primarily diagnostic